Ampakines
Ampakines are positive allosteric modulators of the AMPA receptor, the glutamate receptor behind most fast excitatory signalling in the brain. They do not switch the receptor on; they make it respond more strongly or for longer when glutamate arrives. That has made them candidates for memory, attention and depression, and the class has been in development since the 1990s without a marketed medicine.
IDRA-21 is a benzothiadiazine studied in animals. TAK-653 came out of a pharmaceutical company's depression programme and reached early human trials. Too much AMPA activity is associated with seizures in animal work, which is the class's known risk. Neither compound is approved as a medicine, and products sold as them are research chemicals whose identity rests on the seller.
No posts here yet.